The current study investigated the effects of maternal (F0 generation) lipopolysaccharide administration (50 μg/kg, i.p.)during late gestation on anxiety-like behaviors and FABP7 expression in F1 and F2 offspring, as well as the potential sex-specificity of intergenerational effects. The gene discussed is FABP7; the disease is Anxiety.